BioCentury
ARTICLE | Company News

KaloBios management update

January 19, 2015 8:00 AM UTC

KaloBios Pharmaceuticals Inc. (NASDAQ:KBIO), South San Francisco, Calif. Business: Antibodies, Infectious, Cancer Retired: David Pritchard as president, CEO and a director; he is succeeded by CFO Herb...